Grade: Pharmaceutical Grade

Factory Location: Quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Votexetine mainly exerts its antidepressant effect by increasing the concentration of serotonin (5-HT) in the central nervous system (CNS). Compared with other selective 5-HT reuptake inhibitors (SSRIS) or serotonin - norepinephrine reuptake inhibitors (SNRIS), votexetine has almost no effect on norepinephrine and dopaminergic neurons. Multiple clinical trials have shown that wotioxetine has good efficacy, safety and tolerability in the treatment of MDD.